News

317 results - showing 91 - 100
« 1 ... 7 8 9 10 11 12 ... »
Ordering
Details
ICNA
ICNA
Updated February 08, 2020
This guideline covers diagnosing, assessing and managing cerebral palsy in children and young people from birth up to their 25th birthday. It aims to make sure they get the care and treatment they need for the developmental and clinical comorbidities associated with cerebral palsy, so that they can be as active and independent as possible file File Name: nice_ng62_2017.pdf ...
Read more
New treatment for Anti-NMDA receptor encephalitis
ICNA
ICNA
Updated February 08, 2020
In a study have been published in the journal Neurology researchers from Charité - Universitätsmedizin Berlin and the German Center for Neurodegenerative Diseases (DZNE) using a new treatment regimen have recorded significant progress in patients with Anti-NMDA receptor encephalitis.  In addition to standard treatment, patients received bortezomib, a drug known as proteasome inhibitor that has proven successful in treating patients with plasmacytoma a haematological...
Read more
Systematic Review concludes Zika Virus as cause of birth defects and Guillain-Barre syndrome
ICNA
ICNA
Updated February 08, 2020
Structure of the Zika Virus A systematic review of the evidence confirms that infection with mosquito-borne Zika virus is a cause of Guillain-Barre Syndrome (GBS), in addition to microcephaly and other congenital brain abnormalities, according to a study published in PLOS Medicine by Nicola Low of the University...
Read more
US FDA approves Nusinersen - The first treatment for SMA
ICNA
ICNA
Updated February 08, 2020
The U.S. Food and Drug Administration (FDA) approved Biogen's SPINRAZA™ (nusinersen) under Priority Review for the treatment of spinal muscular atrophy (SMA) in pediatric and adult patients. SPINRAZA (nusinersen)​ is the first and only treatment approved in the U.S. for SMA. In ENDEAR, a pivotal controlled clinical study, infantile-onset SMA patients treated with nusinersen achieved and sustained clinically meaningful improvement...
Read more
ICNA
ICNA
Updated February 08, 2020
Prof. Dieter Janz, Berlin, an iconic figure in the history of epileptology has passed away on December 24, 2016. He was 96 years old. Prof. Janz has made numerous contributions to the field of epileptolgy. In 1957, Janz and Walter Christian described "juvenile myoclonic epilepsy", which was later named after Janz, as a syndrome​. Prof. Janz, among other things, drew attention to the teratogenic effects of antiepileptic drugs and was also one of the first to report the loss of activity antibiotics with the simultaneous use of antiepileptic drugs. His epilepsy clinic in Heidelberg became the hub of epileptology in Germany.​ Prof Janz was...
Read more
ICNA needs your support
ICNA
ICNA
Updated February 08, 2020
Dear colleagues, We are writing today to ask for your support for the International Child Neurology Association (ICNA) and its activities.  http://www.icnapedia.orgThe work that ICNA performs is entirely financed from funds raised.  Membership is now free and has grown considerably to over 2,000 members since we implemented this policy in 2012.   Strategic aims of the ICNA Helping and supporting colleagues from resource poor regions to elevate standards in the clinical practice of child neurology and neurodisability internationally.  ICNA has...
Read more
Helen Cross
Helen Cross
Updated February 08, 2020
It is with great sadness that we report the passing of Brian Neville, formerly Professor of Paediatric Neurology at UCL Institute of Child Health, London 1989-2004, and The Prince of Wales’s Chair of Childhood Epilepsy 2004-2007, in the early hours of 14th December 2016. He had battled ill health over a long period of time. As the first Chair of Paediatric Neurology in the UK, he set up the first academic department of Paediatric Neurology and Neurodisability at Great Ormond Street Hospital and the Institute of Child Health (later UCL-ICH). He wrote the training programmes for Paediatric Neurology...
Read more
Diffusion tensor imaging (DTI) to locate epileptogenic abnormalities not detected by 3T MRI
ICNA
ICNA
Updated February 08, 2020
(A) FA decrease in patient group with right-sided FCD. (B) FA decrease in patient group with left-sided FCD. (C) FA decrease in the analysis of patients with left and right-sided lesions altogether after flipping the MRIs with right-sided FCD lesions. The yellow/red voxel indicated brain regions where the FA was significantly reduced in patients with focal epilepsy when compared to controls. Front. Neurol., 26 July 2012 | https://doi.org/10.3389/fneur.2012.00121 ...
Read more
Parents of Children with Epileptic Encephalopathies Found More Likely to Carry De Novo Mosaic Mutation for Disorder Than Previously thought
ICNA
ICNA
Updated February 08, 2020
Workflow for genomic capture by molecular inversion probes Parents of children with epileptic encephalopathies are far more likely to carry a mosaic mutation than previously thought, according to an international study that was presented at 2016 annual meeting of the American Epilepsy Society in Houston. According to the abstract presented at...
Read more
Joint ESCNP PNU and ACNA conference May 2017
ICNA
ICNA
Updated February 08, 2020
I am happy to announce that the joint meeting of the 21th Egyptian Society of Child Neuropsychiatry Conference (ESCNP), 5th Alexandria University Conference (PNU) and 1st African Child Neurology Conference (ACNA) will be hosted at Helnan Palestine Hotel, Alexandria, Egypt on May 10-11, 2017. The conference is usually attended by a good number of high calibre Pediatric Neurologists, Neurologists, Psychiatrists, Pediatricians from Egypt, Arab & African Countries. 2 Workshops will also be arranged pre and post conference to provide hands on training on Paediatric EMG & EEG. Please send us your abstracts ASAP....
Read more
317 results - showing 91 - 100
« 1 ... 7 8 9 10 11 12 ... »

Join Our Newsletter